PRMT5 catalyzes the methylations of some proteins including NF-κB and Y-box binding protein 1 (YBX1), both are key transcriptional and translational regulators widely recognized as oncogenic drivers in various solid tumors, including CRC [49,50]. Here, PRMT5 is linked to colorectal carcinoma.